Flap  ||| S:0 E:5 ||| JJ
monitoring  ||| S:5 E:16 ||| NN
and  ||| S:16 E:20 ||| CC
patient  ||| S:20 E:28 ||| JJ
management  ||| S:28 E:39 ||| NN
Complications  ||| S:39 E:53 ||| NNS
in  ||| S:53 E:56 ||| IN
free-tissue  ||| S:56 E:68 ||| JJ
transfer  ||| S:68 E:77 ||| NN
patients  ||| S:77 E:86 ||| NNS
cannot  ||| S:86 E:93 ||| RB
be  ||| S:93 E:96 ||| VB
completely  ||| S:96 E:107 ||| RB
prevented ||| S:107 E:116 ||| VBN
;  ||| S:116 E:118 ||| :
however ||| S:118 E:125 ||| RB
,  ||| S:125 E:127 ||| ,
the  ||| S:127 E:131 ||| DT
incidence  ||| S:131 E:141 ||| NN
may  ||| S:141 E:145 ||| MD
be  ||| S:145 E:148 ||| VB
significantly  ||| S:148 E:162 ||| RB
reduced  ||| S:162 E:170 ||| VBN
by  ||| S:170 E:173 ||| IN
a  ||| S:173 E:175 ||| DT
thorough  ||| S:175 E:184 ||| JJ
preoperative  ||| S:184 E:197 ||| JJ
evaluation  ||| S:197 E:208 ||| NN
and  ||| S:208 E:212 ||| CC
initiation  ||| S:212 E:223 ||| NN
of  ||| S:223 E:226 ||| IN
prophylactic  ||| S:226 E:239 ||| JJ
strategies ||| S:239 E:249 ||| NNS
,  ||| S:249 E:251 ||| ,
meticulous  ||| S:251 E:262 ||| JJ
surgical  ||| S:262 E:271 ||| JJ
technique ||| S:271 E:280 ||| NN
,  ||| S:280 E:282 ||| ,
and  ||| S:282 E:286 ||| CC
diligent  ||| S:286 E:295 ||| JJ
postoperative  ||| S:295 E:309 ||| JJ
monitoring ||| S:309 E:319 ||| NN
.  ||| S:319 E:321 ||| .
Emergent  ||| S:321 E:330 ||| JJ
exploration  ||| S:330 E:342 ||| NN
must  ||| S:342 E:347 ||| MD
be  ||| S:347 E:350 ||| VB
performed  ||| S:350 E:360 ||| VBN
soon  ||| S:360 E:365 ||| RB
after  ||| S:365 E:371 ||| IN
obstruction  ||| S:371 E:383 ||| NN
occurs  ||| S:383 E:390 ||| VBZ
if  ||| S:390 E:393 ||| IN
it  ||| S:393 E:396 ||| PRP
is  ||| S:396 E:399 ||| VBZ
to  ||| S:399 E:402 ||| TO
be  ||| S:402 E:405 ||| VB
successful ||| S:405 E:415 ||| JJ
,  ||| S:415 E:417 ||| ,
and  ||| S:417 E:421 ||| CC
early  ||| S:421 E:427 ||| JJ
exploration  ||| S:427 E:439 ||| NN
and  ||| S:439 E:443 ||| CC
repair  ||| S:443 E:450 ||| NN
is  ||| S:450 E:453 ||| VBZ
likely  ||| S:453 E:460 ||| RB
in  ||| S:460 E:463 ||| IN
compromised  ||| S:463 E:475 ||| JJ
flaps  ||| S:475 E:481 ||| NNS
if  ||| S:481 E:484 ||| IN
they  ||| S:484 E:489 ||| PRP
are  ||| S:489 E:493 ||| VBP
monitored  ||| S:493 E:503 ||| VBN
frequently  ||| S:503 E:514 ||| RB
in  ||| S:514 E:517 ||| IN
the  ||| S:517 E:521 ||| DT
initial  ||| S:521 E:529 ||| JJ
postoperative  ||| S:529 E:543 ||| JJ
period ||| S:543 E:549 ||| NN
.  ||| S:549 E:551 ||| .
This  ||| S:551 E:556 ||| DT
article  ||| S:556 E:564 ||| NN
reviews  ||| S:564 E:572 ||| VBZ
the  ||| S:572 E:576 ||| DT
importance  ||| S:576 E:587 ||| NN
of  ||| S:587 E:590 ||| IN
clinical  ||| S:590 E:599 ||| JJ
management  ||| S:599 E:610 ||| NN
in  ||| S:610 E:613 ||| IN
this  ||| S:613 E:618 ||| DT
patient  ||| S:618 E:626 ||| JJ
population ||| S:626 E:636 ||| NN
,  ||| S:636 E:638 ||| ,
the  ||| S:638 E:642 ||| DT
recommended  ||| S:642 E:654 ||| JJ
frequency  ||| S:654 E:664 ||| NN
of  ||| S:664 E:667 ||| IN
flap  ||| S:667 E:672 ||| JJ
monitoring ||| S:672 E:682 ||| NN
,  ||| S:682 E:684 ||| ,
and  ||| S:684 E:688 ||| CC
the  ||| S:688 E:692 ||| DT
most  ||| S:692 E:697 ||| RBS
commonly  ||| S:697 E:706 ||| RB
used  ||| S:706 E:711 ||| VBN
methods  ||| S:711 E:719 ||| NNS
of  ||| S:719 E:722 ||| IN
monitoring  ||| S:722 E:733 ||| VBG
the  ||| S:733 E:737 ||| DT
transferred  ||| S:737 E:749 ||| JJ
tissue  ||| S:749 E:756 ||| NN
whether  ||| S:756 E:764 ||| IN
or  ||| S:764 E:767 ||| CC
not  ||| S:767 E:771 ||| RB
the  ||| S:771 E:775 ||| DT
flap  ||| S:775 E:780 ||| NN
is  ||| S:780 E:783 ||| VBZ
readily  ||| S:783 E:791 ||| RB
visible ||| S:791 E:798 ||| JJ
.  ||| S:798 E:800 ||| .
The  ||| S:800 E:804 ||| DT
authors  ||| S:804 E:812 ||| NNS
also  ||| S:812 E:817 ||| RB
review  ||| S:817 E:824 ||| VB
the  ||| S:824 E:828 ||| DT
anticoagulants  ||| S:828 E:843 ||| NN
used  ||| S:843 E:848 ||| VBN
and  ||| S:848 E:852 ||| CC
a  ||| S:852 E:854 ||| DT
postoperative  ||| S:854 E:868 ||| JJ
flap  ||| S:868 E:873 ||| NN
monitoring  ||| S:873 E:884 ||| NN
protocol ||| S:884 E:892 ||| NN
.  ||| S:892 E:894 ||| .
